Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where W. Stooker is active.

Publication


Featured researches published by W. Stooker.


Arteriosclerosis, Thrombosis, and Vascular Biology | 2006

N(epsilon)-(carboxymethyl)lysine depositions in intramyocardial blood vessels in human and rat acute myocardial infarction: a predictor or reflection of infarction?

Alexi Baidoshvili; Paul A.J. Krijnen; Koba Kupreishvili; C. Ciurana; W. Bleeker; R. Nijmeijer; C.A. Visser; F.C. Visser; Chris J. L. M. Meijer; W. Stooker; L. Eijsman; V.W.M. van Hinsbergh; C.E. Hack; H.W.M. Niessen; C.G. Schalkwijk

Objective—Advanced glycation end products (AGEs), such as Nϵ-(carboxymethyl)lysine (CML), are implicated in vascular disease. We previously reported increased CML accumulation in small intramyocardial blood vessels in diabetes patients. Diabetes patients have an increased risk for acute myocardial infarction (AMI). Here, we examined a putative relationship between CML and AMI. Methods and Results—Heart tissue was stained for CML, myeloperoxidase, and E-selectin in AMI patients (n=26), myocarditis patients (n=17), and control patients (n=15). In AMI patients, CML depositions were 3-fold increased compared with controls in the small intramyocardial blood vessels and predominantly colocalized with activated endothelium (E-selectin–positive) both in infarction and noninfarction areas. A trend of increased CML positivity of the intima of epicardial coronary arteries did not reach significance in AMI patients. In the rat heart AMI model, CML depositions were undetectable after 24 hours of reperfusion, but became clearly visible after 5 days of reperfusion. In line with an inflammatory contribution, human myocarditis was also accompanied by accumulation of CML on the endothelium of intramyocardial blood vessels. Conclusions—CML, present predominantly on activated endothelium in small intramyocardial blood vessels in patients with AMI, might reflect an increased risk for AMI rather than being a result of AMI.


The Annals of Thoracic Surgery | 2000

Functional properties of the saphenous vein harvested by minimally invasive techniques

Myra Rinia-Feenstra; W. Stooker; Ruud de Graaf; Jaap J. Kloek; Martin Pfaffendorf; Bas A.J.M. de Mol; Pieter A. van Zwieten

BACKGROUND Since surgical techniques affect the functional properties of the vessel wall, the present study investigated the influence of minimally invasive harvesting techniques on the vascular reactivity of the saphenous vein. METHODS Saphenous vein remnants were obtained after aortocoronary bypass operation from patients subjected to conventional (n = 6), mediastinoscope-assisted (n = 4), or endoscope-assisted venectomy (n = 5). After preservation in University of Wisconsin solution (UW), ring preparations were mounted in a standard organ bath setup and concentration-response curves were constructed for phenylephrine, sodium nitroprusside, and acetylcholine. RESULTS Saphenous vein reactivity was not altered after preservation in UW. For the vein preparations harvested by means of the three venectomy methods, no differences were demonstrated for responses to KCl, phenylephrine, or sodium nitroprusside. The maximal endothelium-dependent acetylcholine-induced dilation of precontracted vein rings varied between 5% and 12%, independent of the surgical technique applied. CONCLUSIONS It was demonstrated that minimally invasive surgical techniques for harvesting the saphenous vein, which are developed to reduce postoperative complications at the site of explantation, did not affect the vascular reactivity in a different manner than the conventional method.


Cardiovascular Pathology | 2003

Surgical sealant in the prevention of early vein graft injury in an ex vivo model

W. Stooker; H.W.M. Niessen; Evert K. Jansen; Jan Fritz; W.R. Wildevuur; V.W.M. Van Hinsbergh; R.H. Wildevuur; L. Eijsman

BACKGROUND The amelioration of the adaptation process (arterialisation) of the vein graft wall to the arterial circulation in coronary artery bypass surgery by using extravascular support is clearly established in animal models and in in vitro and ex vivo set-ups. This support consists of some form of external graft-supporting modality like a prosthetic graft of stent. The clinical application of perivenous support, however, is hampered due to the fact that no easy applicable external support is available. Considering that application in the form of a spray is the most convenient modality, we evaluated whether polyethylene glycol is capable of providing adequate perivenous support. Polyethylene glycol is a synthetic, biodegradable product, used in cardiac surgery as a sealant, and is commercially available in the form of a spray. METHODS Segments of human saphenous vein graft obtained during coronary artery bypass graft (CABG) procedures were placed in an ex vivo model, a side loop of the extracorporeal perfusion circuit, and perfused with autologous blood, making the circumstances identical to the implanted saphenous vein grafts concerning pressure, temperature, level of complement and leukocyte activation and blood pressure. Alternately around every other study vein graft segment polyethylene glycol was applied. Unsupported grafts served as control. After 1 min of solidification, perfusion was started with a pressure of about 60 mmHg (nonpulsatile flow). Perfusion was maintained for 60 min, after which the grafts were collected for light microscopy and electron microscopy. RESULTS Light microscopy and electron microscopy showed remarkable attenuation of endothelial cell loss and less injury of smooth muscle cells of the circular and longitudinal layer of the media in the supported group compared to the nonsupported vein graft segments. CONCLUSION Polyethylene glycol is able to provide adequate external vein graft support, preventing overdistension, in an ex vivo model. This provides a basis for clinical application. Further investigation is warranted to evaluate long-term effects.


European Journal of Clinical Investigation | 2010

Activated complement is more extensively present in diseased aortic valves than naturally occurring complement inhibitors: a sign of ongoing inflammation.

M. ter Weeme; Alexander B. A. Vonk; Koba Kupreishvili; M. Van Ham; Sacha Zeerleder; Diana Wouters; W. Stooker; L. Eijsman; V.W.M. van Hinsbergh; Paul A.J. Krijnen; H.W.M. Niessen

Eur J Clin Invest 2010; 40 (1): 4–10


Pacing and Clinical Electrophysiology | 1998

Unusual approach of a pacemaker electrode in a patient with a silent superior vena cava syndrome.

Carel C. de Cock; W. Stooker; Cees A. Visser

A man with a history of bilateral pectoral pocket infection and subsequent pacemaker implantation with a screw‐in epicardial lead was referred because of increasing lead impedance. Venography revealed bilateral total occlusion of the subclavian and innominate veins with extensive collateral formation in this asymptomatic patient. Both internal jugular veins were also totally occluded. Because repeated pacemaker implantation using epicardial leads resulted in increasing lead impedance of the ventricular lead within 1 year after implant, an alternative approach was found using the superior caval vein with minimal invasive thoracotomy for single lead VDD pacing.


European Journal of Clinical Investigation | 2008

Increased infiltration of Chlamydophila pneumoniae in the vessel wall of human veins after perfusion

Koba Kupreishvili; M. ter Weeme; Servaas A. Morré; A. J. C. Van Den Brule; M. A. J. M. Huybregts; Paul H.A. Quax; J. ten Velden; V.W.M. van Hinsbergh; W. Stooker; Leon Eijsman; Hans W.M. Niessen

Background  Several studies have suggested an association between Chlamydophila pneumoniae (Cp) infection and atherosclerosis. A recent study detected Cp DNA in the saphenous vein of 12% of all patients before bypass grafting and in 38% of failed grafts. We used a system in which human veins were perfused with autologous blood under arterial pressure.


Journal of Clinical Pathology | 2000

Microorganisms in the aetiology of atherosclerosis

Servaas A. Morré; W. Stooker; W K Lagrand; A. J. C. Van Den Brule; Hans W.M. Niessen


European Journal of Cardio-Thoracic Surgery | 2002

Perivenous application of fibrin glue reduces early injury to the human saphenous vein graft wall in an ex vivo model.

W. Stooker; Hans W.M. Niessen; W.R. Wildevuur; V.W.M. van Hinsbergh; J. Fritz; Evert K. Jansen; Ch.R.H. Wildevuur; L. Eijsman


Atherosclerosis | 2004

Nε-(Carboxymethyl)lysine depositions in human aortic heart valves: similarities with atherosclerotic blood vessels

Alexi Baidoshvili; Hans W.M. Niessen; W. Stooker; Rien A.J.M. Huybregts; C. Erik Hack; Jan A. Rauwerda; Chris J. L. M. Meijer; Leon Eijsman; Victor W.M. van Hinsbergh; Casper G. Schalkwijk


Artificial Organs | 1998

Let's understand nature better : De- and regeneration of autologous and artificial small caliber vascular grafts

W. Stooker; Charles Wildevuur; Vwm van Hinsbergh; L. Eijsman

Collaboration


Dive into the W. Stooker's collaboration.

Top Co-Authors

Avatar

L. Eijsman

VU University Amsterdam

View shared research outputs
Top Co-Authors

Avatar

Hans W.M. Niessen

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

V.W.M. van Hinsbergh

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

H.W.M. Niessen

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Koba Kupreishvili

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Leon Eijsman

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Paul A.J. Krijnen

VU University Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge